JP2023504185A5 - - Google Patents

Info

Publication number
JP2023504185A5
JP2023504185A5 JP2022532869A JP2022532869A JP2023504185A5 JP 2023504185 A5 JP2023504185 A5 JP 2023504185A5 JP 2022532869 A JP2022532869 A JP 2022532869A JP 2022532869 A JP2022532869 A JP 2022532869A JP 2023504185 A5 JP2023504185 A5 JP 2023504185A5
Authority
JP
Japan
Prior art keywords
epitope
cells
antigen
soluble polyvalent
binding sites
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022532869A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023504185A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/063177 external-priority patent/WO2021113558A2/en
Publication of JP2023504185A publication Critical patent/JP2023504185A/ja
Publication of JP2023504185A5 publication Critical patent/JP2023504185A5/ja
Pending legal-status Critical Current

Links

JP2022532869A 2019-12-03 2020-12-03 γδT細胞集団を多価薬剤で増殖させるための方法及びその組成物 Pending JP2023504185A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962943166P 2019-12-03 2019-12-03
US62/943,166 2019-12-03
PCT/US2020/063177 WO2021113558A2 (en) 2019-12-03 2020-12-03 METHODS FOR EXPANDING γδ T-CELL POPULATIONS WITH MULTIVALENT AGENTS AND COMPOSITIONS THEREOF

Publications (2)

Publication Number Publication Date
JP2023504185A JP2023504185A (ja) 2023-02-01
JP2023504185A5 true JP2023504185A5 (https=) 2024-01-31

Family

ID=76222296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022532869A Pending JP2023504185A (ja) 2019-12-03 2020-12-03 γδT細胞集団を多価薬剤で増殖させるための方法及びその組成物

Country Status (10)

Country Link
US (1) US20230009275A1 (https=)
EP (1) EP4072567A4 (https=)
JP (1) JP2023504185A (https=)
KR (1) KR20220123652A (https=)
CN (1) CN115397976A (https=)
AU (1) AU2020398623A1 (https=)
CA (1) CA3160609A1 (https=)
IL (1) IL293459A (https=)
MX (1) MX2022006547A (https=)
WO (1) WO2021113558A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025504363A (ja) * 2022-01-05 2025-02-12 インヒブルクス バイオサイエンシズ インコーポレイテッド γδT細胞結合ポリペプチド及びその使用
EP4508193A4 (en) * 2022-04-11 2026-04-29 In8Bio Inc IPSC-BASED GAMMA-DELTA T LYMPHOCYTES: COMPOSITIONS AND METHODS OF USE
CN121793981A (zh) * 2023-10-18 2026-04-03 南京传奇生物科技有限公司 Pan T细胞及其制造方法
WO2026013158A1 (en) * 2024-07-10 2026-01-15 Cytospire Therapeutics Limited Antibodies binding to constant domains of gamma delta t-cell receptors
WO2026013159A1 (en) * 2024-07-10 2026-01-15 Cytospire Therapeutics Limited Antibodies binding to constant domains of gamma delta t-cell receptors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001022816A1 (en) * 1999-09-30 2001-04-05 National Jewish Medical And Research Center MODULATION OF ηδ T CELLS TO REGULATE AIRWAY HYPERRESPONSIVENESS
CN106687584B (zh) * 2014-09-04 2021-08-13 干细胞技术公司 用于t细胞或nk细胞活化和扩增的可溶性抗体复合物
IL297773B2 (en) * 2014-11-17 2024-07-01 Adicet Bio Inc Engineered gamma delta t-cells
US11299708B2 (en) * 2016-05-12 2022-04-12 Adicet Bio, Inc. Methods for selective expansion of γδ T-cell populations and compositions thereof
GB201707048D0 (en) * 2017-05-03 2017-06-14 King S College London Expansion of gamma delta cells, compositions, and methods of use thereof
MX2020005005A (es) * 2017-11-15 2020-08-27 Adicet Bio Inc Métodos para la expansión selectiva de poblaciones de células t gamma delta delta 3 y composiciones de estas.
DE102017127984B4 (de) * 2017-11-27 2019-12-05 Immatics US, Inc. Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen
SG11202105860QA (en) * 2018-12-03 2021-07-29 Adicet Bio Inc Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof

Similar Documents

Publication Publication Date Title
JP2023504185A5 (https=)
JP2021000117A5 (https=)
RU2018118575A (ru) Способы культивирования клеток и наборы и устройство для них
Sarkar et al. The role of T helper type 17 cells in inflammatory arthritis
RU2016143385A (ru) Продукты определенного состава, содержащие генетически модифицированные т-клетки
JP2016509839A5 (https=)
Boyman et al. IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia
JP2024041873A5 (https=)
JP5894538B2 (ja) 炎症性ヒトTh17細胞の増殖および機能を決定的に調節するICOS
JP2018531035A5 (https=)
JP2024096899A5 (https=)
JP2024506557A5 (https=)
JP2021502414A5 (https=)
JP2006519228A5 (ja) 抗原に対し霊長類を免疫寛容化する抗体の使用法
CA2796379A1 (en) Method for proliferation of antigen-specific t cells
Oppenheim et al. The role of cytokines in cancer
CA2148712A1 (en) Peripheralization of hematopoietic stem cells
JP2022541523A5 (https=)
JP2022553822A5 (https=)
CN113660942A (zh) 嵌合细胞因子受体
CN114901684B (zh) 粒细胞集落刺激因子受体(g-csfr)的经修饰胞外结构域和结合其的细胞因子
Kusters et al. Cytokines and immune responses in murine atherosclerosis
JP2020527044A5 (https=)
R Ghali et al. Targeting IL-17 and IL-23 in immune mediated renal disease
Yang et al. Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma